Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Amisulpride - Acacia Pharma

Next Previous
Drug Profile

Amisulpride - Acacia Pharma

Alternative Names: amisulpride injection; APD-403; APD-421; BAREMSIS®; BARHEMSYS

Latest Information Update: 17 Dec 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Acacia Pharma
  • Class Antidepressants; Antiemetics; Antipsychotics; Benzamides; Pyrrolidines; Small molecules; Sulfones
  • Mechanism of Action Dopamine D2 receptor antagonists; Dopamine D3 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Postoperative nausea and vomiting

Highest Development Phases

  • Marketed Postoperative nausea and vomiting
  • Phase II Chemotherapy-induced nausea and vomiting

Most Recent Events

  • 17 Dec 2024 No development reported - Preregistration for Postoperative nausea and vomiting (Prevention) in European Union (IV)
  • 13 Mar 2023 Adverse events data from a phase III trial in Postoperative nausea and vomiting released by Eagle Pharmaceuticals
  • 13 Mar 2023 Drug interactions data released by Eagle Pharmaceuticals

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top